What congenital malformation risk has been reported in children born to women with epilepsy who took phenobarbital during pregnancy?

Congenital malformations were reported in 6–7% of children born to women with epilepsy exposed to phenobarbital during pregnancy, compared with 2–3% in the general population; the risk is dose-dependent, but no dose has been found without risk.